Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Egln2 | Rat | 1,10-phenanthroline | decreases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | 1,10-phenanthroline results in decreased expression of EGLN2 mRNA | CTD | PMID:19502547 | Egln2 | Rat | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile | increases expression | EXP | | 6480464 | Citalopram results in increased expression of EGLN2 mRNA | CTD | PMID:28467792 | Egln2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Egln2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EGLN2 mRNA | CTD | PMID:17942748 | Egln2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Egln2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EGLN2 mRNA | CTD | PMID:17942748 | Egln2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EGLN2 mRNA | CTD | PMID:33387578 | Egln2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Egln2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of EGLN2 mRNA | CTD | PMID:21570461 | Egln2 | Rat | 2-butoxyethanol | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of EGLN2 mRNA | CTD | PMID:19812364 | Egln2 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Egln2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of EGLN2 exon | CTD | PMID:33297965 | Egln2 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Egln2 | Rat | 5-chloro-7-iodoquinolin-8-ol | decreases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | Clioquinol results in decreased expression of EGLN2 mRNA | CTD | PMID:19502547 | Egln2 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of EGLN2 mRNA | CTD | PMID:16483693 | Egln2 | Rat | benzene | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | Benzene results in increased expression of EGLN2 mRNA | CTD | PMID:19162166 | Egln2 | Rat | benzo[a]pyrene | decreases expression | ISO | Egln2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of EGLN2 mRNA | CTD | PMID:20127859 | Egln2 | Rat | benzo[a]pyrene | decreases methylation | ISO | EGLN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of EGLN2 3' UTR; Benzo(a)pyrene results in decreased methylation of more ... | CTD | PMID:27901495 | Egln2 | Rat | benzo[a]pyrene | increases methylation | ISO | EGLN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of EGLN2 promoter | CTD | PMID:27901495 | Egln2 | Rat | benzo[a]pyrene | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of EGLN2 mRNA | CTD | PMID:22228805 | Egln2 | Rat | bisphenol A | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of EGLN2 mRNA | CTD | PMID:20678512 | Egln2 | Rat | bisphenol A | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of EGLN2 mRNA | CTD | PMID:32156529 | Egln2 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Egln2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of EGLN2 mRNA | CTD | PMID:25181051 | Egln2 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of EGLN2 gene | CTD | PMID:28505145 | Egln2 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Egln2 | Rat | Butylbenzyl phthalate | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased expression of EGLN2 mRNA | CTD | PMID:28392331 | Egln2 | Rat | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of EGLN2 mRNA | CTD | PMID:19167457 | Egln2 | Rat | calcitriol | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of EGLN2 mRNA | CTD | PMID:21592394 | Egln2 | Rat | calcitriol | multiple interactions | ISO | EGLN2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EGLN2 mRNA | CTD | PMID:21592394 | Egln2 | Rat | CGP 52608 | multiple interactions | ISO | EGLN2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to EGLN2 gene] | CTD | PMID:28238834 | Egln2 | Rat | chlorpyrifos | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of EGLN2 mRNA | CTD | PMID:37019170 | Egln2 | Rat | cisplatin | decreases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of EGLN2 mRNA | CTD | PMID:27392435 | Egln2 | Rat | citalopram | increases expression | EXP | | 6480464 | Citalopram results in increased expression of EGLN2 mRNA | CTD | PMID:28467792 | Egln2 | Rat | cobalt dichloride | decreases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of EGLN2 mRNA | CTD | PMID:15695372 | Egln2 | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of EGLN2 protein | CTD | PMID:22982409 | Egln2 | Rat | cobalt(2+) sulfate | decreases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | cobalt sulfate results in decreased expression of EGLN2 mRNA | CTD | PMID:19502547 | Egln2 | Rat | DDT | increases methylation | EXP | | 6480464 | DDT results in increased methylation of EGLN2 gene | CTD | PMID:30207508 | Egln2 | Rat | dextran sulfate | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of EGLN2 mRNA | CTD | PMID:35093514 | Egln2 | Rat | Dibutyl phosphate | affects expression | ISO | EGLN2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of EGLN2 mRNA | CTD | PMID:37042841 | Egln2 | Rat | dinophysistoxin 1 | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | dinophysistoxin 1 results in increased expression of EGLN2 mRNA | CTD | PMID:28939011 | Egln2 | Rat | epoxiconazole | decreases expression | ISO | Egln2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of EGLN2 mRNA | CTD | PMID:35436446 | Egln2 | Rat | folic acid | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | Folic Acid results in increased expression of EGLN2 mRNA | CTD | PMID:25629700 | Egln2 | Rat | lipopolysaccharide | multiple interactions | ISO | EGLN2 (Homo sapiens) | 6480464 | EGLN2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] | CTD | PMID:40024754 | Egln2 | Rat | nickel atom | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | Nickel results in increased expression of EGLN2 mRNA | CTD | PMID:20053437 | Egln2 | Rat | paraquat | decreases expression | ISO | Egln2 (Mus musculus) | 6480464 | Paraquat results in decreased expression of EGLN2 mRNA | CTD | PMID:21371552 | Egln2 | Rat | pirinixic acid | increases expression | ISO | Egln2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of EGLN2 mRNA | CTD | PMID:18445702 | Egln2 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of EGLN2 mRNA | CTD | PMID:19281266 | Egln2 | Rat | testosterone | multiple interactions | ISO | EGLN2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EGLN2 mRNA | CTD | PMID:21592394 | Egln2 | Rat | testosterone | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | Testosterone results in increased expression of EGLN2 mRNA | CTD | PMID:21592394 | Egln2 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of EGLN2 mRNA | CTD | PMID:34492290 | Egln2 | Rat | titanium dioxide | decreases methylation | ISO | Egln2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of EGLN2 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Egln2 | Rat | triphenyl phosphate | affects expression | ISO | EGLN2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of EGLN2 mRNA | CTD | PMID:37042841 | Egln2 | Rat | urethane | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | Urethane results in increased expression of EGLN2 mRNA | CTD | PMID:28818685 | Egln2 | Rat | valproic acid | increases methylation | ISO | EGLN2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of EGLN2 gene | CTD | PMID:29154799 | Egln2 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of EGLN2 mRNA | CTD | PMID:23034163 | Egln2 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of EGLN2 mRNA | CTD | PMID:22615374 | Egln2 | Rat | vitamin E | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of EGLN2 mRNA | CTD | PMID:19244175 | Egln2 | Rat | zoledronic acid | increases expression | ISO | EGLN2 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of EGLN2 mRNA | CTD | PMID:20977926 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















